Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SARTORIUS (SARTF : OTC)
 
 • Company Description   
Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany.

Number of Employees: 13,832

 
 • Price / Volume Information   
Yesterday's Closing Price: $342.74 Daily Weekly Monthly
20 Day Moving Average: 2 shares
Shares Outstanding: 34.23 (millions)
Market Capitalization: $11,732.06 (millions)
Beta: 0.69
52 Week High: $947.00
52 Week Low: $292.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.93% 15.91%
12 Week -10.86% -2.01%
Year To Date -35.42% -32.78%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
OTTO-BRENNER-STRASSE 20
-
GOETTINGEN,2M 37079
DEU
ph: 49-55-130-80
fax: 49-55-1308-3289
ben.orzelek@sartorius.com http://www.sartorius.com
 
 • General Corporate Information   
Officers
Joachim Kreuzburg - Chief Executive Officer and Chairman
Rainer Lehmann - Chief Financial Officer
John Gerard Mackay - Member of the Executive Board
Rene Faber - Member of the Executive Board
Gerry Mackay - Member of the Executive Board

Peer Information
SARTORIUS (ABMD)
SARTORIUS (DMDS)
SARTORIUS (CPWY.)
SARTORIUS (EQUR)
SARTORIUS (ECIA)
SARTORIUS (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: D6705R101
SIC: 3843
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/20/22
Share - Related Items
Shares Outstanding: 34.23
Most Recent Split Date: (:1)
Beta: 0.69
Market Capitalization: $11,732.06 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $2.44 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $10.37 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/20/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 33.05
Trailing 12 Months: 33.70
PEG Ratio: -
Price Ratios
Price/Book: 5.32
Price/Cash Flow: 12.64
Price / Sales: 2.75
EPS Growth
vs. Year Ago Period: 28.64%
vs. Previous Quarter: 11.84%
Sales Growth
vs. Year Ago Period: 20.58%
vs. Previous Quarter: 9.01%
ROE
03/31/22 - 33.80
12/31/21 - 33.40
09/30/21 - 31.98
ROA
03/31/22 - 10.54
12/31/21 - 10.13
09/30/21 - 9.68
Current Ratio
03/31/22 - 1.21
12/31/21 - 1.16
09/30/21 - 1.21
Quick Ratio
03/31/22 - 0.58
12/31/21 - 0.58
09/30/21 - 0.65
Operating Margin
03/31/22 - 16.27
12/31/21 - 16.05
09/30/21 - 15.56
Net Margin
03/31/22 - 11.99
12/31/21 - 9.33
09/30/21 - 11.72
Pre-Tax Margin
03/31/22 - 22.80
12/31/21 - 19.38
09/30/21 - 23.20
Book Value
03/31/22 - 64.43
12/31/21 - 59.46
09/30/21 - 59.08
Inventory Turnover
03/31/22 - 2.03
12/31/21 - 2.12
09/30/21 - 2.25
Debt-to-Equity
03/31/22 - 0.88
12/31/21 - 1.01
09/30/21 - 1.03
Debt-to-Capital
03/31/22 - 46.90
12/31/21 - 50.26
09/30/21 - 50.70
 

Powered by Zacks Investment Research ©